Stay updated on IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial
Sign up to get notified when there's something new on the IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial page.

Latest updates to the IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial page
- Check6 days agoChange DetectedRevision line updated from v3.5.3 to v3.5.4, indicating a new version of the site framework. This change does not modify the study content or related data on the page.SummaryDifference0.1%

- Check13 days agoChange Detected‘Melanoma’ and the related topics/MedlinePlus Genetics link were removed from the page. This change alters the disease context and associated resource connections on the study page, affecting discoverability and navigation for users seeking information about melanoma.SummaryDifference0.2%

- Check20 days agoChange DetectedMelanoma has been added to the related topics section, along with MedlinePlus Genetics as a related topic. The revision label on the page has been updated from v3.5.2 to v3.5.3.SummaryDifference0.2%

- Check27 days agoChange DetectedRemoved general “Melanoma” topic links/related topics sections (including MedlinePlus genetics-related entries). This affects browsing/reference links but not the study’s core details.SummaryDifference0.2%

- Check34 days agoChange DetectedAdded Melanoma and related topic MedlinePlus Genetics, and updated the site revision from v3.5.0 to v3.5.2.SummaryDifference0.2%

- Check41 days agoChange DetectedMelanoma is removed from the page's conditions list, and MedlinePlus Genetics is removed from related topics.SummaryDifference0.2%

Stay in the know with updates to IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial page.